The global Patient
Monitoring Devices Market size is estimated to generate revenues of more
than USD 80.75 billion by 2030, growing at a CAGR of around 8.3% from
2022 to 2030
The report covers SWOT analysis, market valuation, competitive spectrum,
regional share, and revenue predictions. The report offers an analysis of the global patient
monitoring devices Market for the period 2017 to 2030, wherein 2022 to 2030 is
the forecast period and 2021 is considered as the base year.
The wide application portfolio of patient monitoring devices market is
one of factors driving the growth of market worldwide. The global market is
moderately competitive with a blend of global and regional players. The markets
key players invest significantly in R and D to enhance their offerings. The
entire ecosystem is composed of multiple participants. Every participant of the
ecosystem is an equal contributor to the growth of global market.
Why should
you invest in this report?
If you are aiming to enter the global patient
monitoring devices Market, this report is a comprehensive guide that provides
crystal clear insights into this niche market. All the major application areas
for patient monitoring devices are covered in this report and information is
given on the important regions of the world where this market is likely to boom
during the forecast period of 2022-2030, so that you can plan your strategies
to enter this market accordingly. Besides, through this report, you can have a
complete grasp of the level of competition you will be facing in this hugely
competitive market and if you are an established player in this market already,
this report will help you gauge the strategies that your competitors have
adopted to stay as market leaders in this market. For new entrants to this
market, the voluminous data provided in this report is invaluable.
Report Scope of the Patient Monitoring Devices Market
| Report Coverage | Details |
| Market Size | USD 80.75 Billion by 2030 |
| Growth Rate | CAGR of 8.3% From 2021 to 2030 |
| Base Year | 2020 |
| Historic Data | 2017 to 2020 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Product, End User |
| Regional Scope | North America, APAC, Europe, Latin America, MEAN, Rest of the World |
| Companies Mentioned | Abbott Laboratories, Hill-Rom Holdings, Inc., Drägerwerk AG & Co. KGaA, Edwards Lifesciences Corporation, OMRON Corporation, Masimo Corporation, Compumedics Limited, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Nihon Kohden Corporation, Natus Medical, Medtronic plc (Ireland), Koninklijke Philips N.V., GE Healthcare, Getinge AB, Boston Scientific Corporation, Dexcom, Inc., Nonin, BIOTRONIK, SCHILLER, and BioTelemetry, Inc. |
Report Structure:
- pertinent
market numbers of the global patient monitoring devices market along with
the CAGR for the forecast period 2022-2030
- detailed
definitions of different types of patient monitoring devices, which gives
clarity about what this market is all about and also defines the scope of
this report
- macroeconomic
factors influencing the global patient monitoring devices market, along
with market opportunity analysis
- key
trends likely to impact the global patient monitoring devices market
- PESTLE
analysis of all the regions as per the market taxonomy
- Porter’s
Five Force Analysis of all the regions as given in the market taxonomy
Global market analysis and forecast:
- the
global patient monitoring devices market analysis and forecast by product
type, by application, by region and others
- key
market metrics such as the BPS analysis, year-on-year growth rates,
absolute dollar opportunity and market attractiveness analysis of the
global patient monitoring devices market
Regional market analysis and forecast:
- Regional
patient monitoring devices market analysis and forecast
- Regional
market dynamics including the drivers, restraints and trends applicable
across different regions in the patient monitoring devices market along
with factors encouraging the growth of this market as well as the factors
hampering the growth of this market
- Regional
trends – both long term and short term
View Full Report@
https://www.precedenceresearch.com/patient-monitoring-devices-market
Competitive landscape:
- the
competitive landscape of this global report
- information
on the various leading companies in the global market
- a
dashboard view of the key companies operating in the global market along
with their important information and broad strategy adopted to stay as
leaders in the global market
- key
company profiles along with important information such as company details,
company description, product portfolio along with key developments concerning
the company and strategic analysis
Some of the prominent players in patient
monitoring devices market include:
Abbott Laboratories, Hill-Rom Holdings, Inc.,
Drägerwerk AG & Co. KGaA, Edwards Lifesciences Corporation, OMRON
Corporation, Masimo Corporation, Compumedics Limited, Shenzhen Mindray
Bio-Medical Electronics Co., Ltd., Nihon Kohden Corporation, Natus Medical,
Medtronic plc (Ireland), Koninklijke Philips N.V., GE Healthcare, Getinge AB,
Boston Scientific Corporation, Dexcom, Inc., Nonin, BIOTRONIK, SCHILLER, and
BioTelemetry, Inc.
Market Segmentation:
By Product
- Cardiac Monitoring
Devices
- ECG Devices
- Implantable Loop
Recorders
- Event Monitors
- Mobile Cardiac
Telemetry Monitors
- Smart/Wearable ECG
Monitors
- Blood Glucose
Monitoring Systems
- Self-monitoring Blood
Glucose Systems
- Continuous Glucose
Monitoring Systems
- Multi-parameter
Monitoring Devices
- Low-acuity Monitoring
Devices
- Mid-acuity Monitoring
Devices
- High-acuity
Monitoring Devices
- Temperature Monitoring
Devices
- Handheld Temperature
Monitoring Devices
- Table-top Temperature
Monitoring Devices
- Wearable Continuous
Monitoring Devices
- Invasive Temperature
Monitoring Devices
- Smart Temperature
Monitoring Devices
- Respiratory Monitoring
Devices
- Pulse Oximeters
- Spirometers
- Capnographs
- Peak Flow Meters
- Hemodynamic/Pressure
Monitoring Devices
- Hemodynamic Monitors
- Blood Pressure
Monitors
- Disposables
- Fetal& Neonatal
Monitoring Devices
- Fetal Monitoring
Devices
- Neonatal Monitoring
Devices
- Neuromonitoring
Devices
- Electroencephalograph
Machines
- Electromyography
Machines
- Cerebral Oximeters
- Intracranial Pressure
Monitors
- Magnetoencephalograph
Machines
- Transcranial Doppler
Machines
- Weight Monitoring
Devices
- Digital
- Analog
- Other Patient
Monitoring Devices
By End-use
- Hospitals
- Home Care Settings
- Ambulatory Surgery
Centers
- Others
By Geography
- North America
- U.S.
- Canada
- Mexico
- Europe
- U.K.
- Germany
- France
- Russia
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of
Asia-Pacific
- LAMEA
- Latin America
- Middle East
- Africa
Research Methodology
In this report, historical data, primary
responses and public domain data has been thoroughly analyzed to infer the
market size. Revenue of companies operating in the global market has been
benchmarked to ascertain the market size for the base year. Macroeconomic
indicators such as GDP and industry growth have been considered to determine
the market size for the forecast period. The historical growth trend of end-use
industries, market participants’ performance, as well as the present
macro-economic outlook has been taken into consideration for estimating the
overall market trend forecast. This data is then validated using the
triangulation method and extensively scrutinized using advanced tools to garner
quantitative and qualitative insights into the global patient monitoring
devices.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2.
Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions &
Limitations
Chapter 3.
Executive Summary
3.1. Market Snapshot
Chapter 4.
Market Variables and Scope
4.1. Introduction
4.2. Market
Classification and Scope
4.3. Industry Value
Chain Analysis
4.3.1. Raw Material
Procurement Analysis
4.3.2. Sales and
Distribution Channel Analysis
4.3.3. Downstream Buyer
Analysis
Chapter 5.
Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market
Restraints
5.1.3. Market
Opportunities
5.2. Porter’s Five
Forces Analysis
5.2.1. Bargaining power
of suppliers
5.2.2. Bargaining power
of buyers
5.2.3. Threat of
substitute
5.2.4. Threat of new
entrants
5.2.5. Degree of
competition
Chapter 6.
Competitive Landscape
6.1.1. Company Market
Share/Positioning Analysis
6.1.2. Key Strategies
Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of
Suppliers
6.1.3.2. List of Buyers
Chapter 7.
Global Patient Monitoring Devices Market, By Product
7.1. Patient Monitoring
Devices Market, by Product Type, 2021-2030
7.1.1. Cardiac
Monitoring Devices
7.1.1.1. Market Revenue
and Forecast (2017-2030)
7.1.2. Blood Glucose
Monitoring Systems
7.1.2.1. Market Revenue
and Forecast (2017-2030)
7.1.3. Multi-parameter
Monitoring Devices
7.1.3.1. Market Revenue
and Forecast (2017-2030)
7.1.4. Temperature
Monitoring Devices
7.1.4.1. Market Revenue
and Forecast (2017-2030)
7.1.5. Respiratory
Monitoring Devices
7.1.5.1. Market Revenue
and Forecast (2017-2030)
7.1.6. Hemodynamic/Pressure
Monitoring Devices
7.1.6.1. Market Revenue
and Forecast (2017-2030)
7.1.7. Fetal &
Neonatal Monitoring Devices
7.1.7.1. Market Revenue
and Forecast (2017-2030)
7.1.8. Neuromonitoring
Devices
7.1.8.1. Market Revenue
and Forecast (2017-2030)
7.1.9. Weight
Monitoring Devices
7.1.9.1. Market Revenue
and Forecast (2017-2030)
7.1.10. Others
7.1.10.1. Market
Revenue and Forecast (2017-2030)
Chapter 8.
Global Patient Monitoring Devices Market, By End-use
8.1. Patient Monitoring
Devices Market, by End-use, 2021-2030
8.1.1. Hospitals
8.1.1.1. Market Revenue
and Forecast (2017-2030)
8.1.2. Home Care
Settings
8.1.2.1. Market Revenue
and Forecast (2017-2030)
8.1.3. Ambulatory
Surgery Centers
8.1.3.1. Market Revenue
and Forecast (2017-2030)
8.1.4. Others
8.1.4.1. Market Revenue
and Forecast (2017-2030)
Chapter 9.
Global Patient Monitoring Devices Market, Regional Estimates and Trend
Forecast
9.1. North America
9.1.1. Market Revenue
and Forecast, by Product (2017-2030)
9.1.2. Market Revenue
and Forecast, by End-use (2017-2030)
9.1.3. U.S.
9.1.3.1. Market Revenue
and Forecast, by Product (2017-2030)
9.1.3.2. Market Revenue
and Forecast, by End-use (2017-2030)
9.1.4. Rest of North
America
9.1.4.1. Market Revenue
and Forecast, by Product (2017-2030)
9.1.4.2. Market Revenue
and Forecast, by End-use (2017-2030)
9.2. Europe
9.2.1. Market Revenue
and Forecast, by Product (2017-2030)
9.2.2. Market Revenue
and Forecast, by End-use (2017-2030)
9.2.3. UK
9.2.3.1. Market Revenue
and Forecast, by Product (2017-2030)
9.2.3.2. Market Revenue
and Forecast, by End-use (2017-2030)
9.2.4. Germany
9.2.4.1. Market Revenue
and Forecast, by Product (2017-2030)
9.2.4.2. Market Revenue
and Forecast, by End-use (2017-2030)
9.2.5. France
9.2.5.1. Market Revenue
and Forecast, by Product (2017-2030)
9.2.5.2. Market Revenue
and Forecast, by End-use (2017-2030)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue
and Forecast, by Product (2017-2030)
9.2.6.2. Market Revenue
and Forecast, by End-use (2017-2030)
9.3. APAC
9.3.1. Market Revenue
and Forecast, by Product (2017-2030)
9.3.2. Market Revenue
and Forecast, by End-use (2017-2030)
9.3.3. India
9.3.3.1. Market Revenue
and Forecast, by Product (2017-2030)
9.3.3.2. Market Revenue
and Forecast, by End-use (2017-2030)
9.3.4. China
9.3.4.1. Market Revenue
and Forecast, by Product (2017-2030)
9.3.4.2. Market Revenue
and Forecast, by End-use (2017-2030)
9.3.5. Japan
9.3.5.1. Market Revenue
and Forecast, by Product (2017-2030)
9.3.5.2. Market Revenue
and Forecast, by End-use (2017-2030)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue
and Forecast, by Product (2017-2030)
9.3.6.2. Market Revenue
and Forecast, by End-use (2017-2030)
9.4. MEA
9.4.1. Market Revenue
and Forecast, by Product (2017-2030)
9.4.2. Market Revenue
and Forecast, by End-use (2017-2030)
9.4.3. GCC
9.4.3.1. Market Revenue
and Forecast, by Product (2017-2030)
9.4.3.2. Market Revenue
and Forecast, by End-use (2017-2030)
9.4.4. North Africa
9.4.4.1. Market Revenue
and Forecast, by Product (2017-2030)
9.4.4.2. Market Revenue
and Forecast, by End-use (2017-2030)
9.4.5. South Africa
9.4.5.1. Market Revenue
and Forecast, by Product (2017-2030)
9.4.5.2. Market Revenue
and Forecast, by End-use (2017-2030)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue
and Forecast, by Product (2017-2030)
9.4.6.2. Market Revenue
and Forecast, by End-use (2017-2030)
9.5. Latin America
9.5.1. Market Revenue
and Forecast, by Product (2017-2030)
9.5.2. Market Revenue
and Forecast, by End-use (2017-2030)
9.5.3. Brazil
9.5.3.1. Market Revenue
and Forecast, by Product (2017-2030)
9.5.3.2. Market Revenue
and Forecast, by End-use (2017-2030)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue
and Forecast, by Product (2017-2030)
9.5.4.2. Market Revenue
and Forecast, by End-use (2017-2030)
Chapter 10.
Company Profiles
10.1. Abbott
Laboratories
10.1.1. Company
Overview
10.1.2. Product
Offerings
10.1.3. Financial
Performance
10.1.4. Recent
Initiatives
10.2. Hill-Rom
Holdings, Inc.
10.2.1. Company
Overview
10.2.2. Product
Offerings
10.2.3. Financial
Performance
10.2.4. Recent
Initiatives
10.3. Drägerwerk AG
& Co. KGaA
10.3.1. Company
Overview
10.3.2. Product
Offerings
10.3.3. Financial
Performance
10.3.4. Recent
Initiatives
10.4. Edwards
Lifesciences Corporation
10.4.1. Company
Overview
10.4.2. Product
Offerings
10.4.3. Financial
Performance
10.4.4. Recent
Initiatives
10.5. OMRON Corporation
10.5.1. Company
Overview
10.5.2. Product
Offerings
10.5.3. Financial
Performance
10.5.4. Recent
Initiatives
10.6. Masimo
Corporation
10.6.1. Company
Overview
10.6.2. Product
Offerings
10.6.3. Financial
Performance
10.6.4. Recent
Initiatives
10.7. Compumedics
Limited
10.7.1. Company
Overview
10.7.2. Product
Offerings
10.7.3. Financial
Performance
10.7.4. Recent
Initiatives
10.8. Shenzhen Mindray
Bio-Medical Electronics Co., Ltd.
10.8.1. Company
Overview
10.8.2. Product
Offerings
10.8.3. Financial
Performance
10.8.4. Recent
Initiatives
10.9. Nihon Kohden
Corporation
10.9.1. Company
Overview
10.9.2. Product
Offerings
10.9.3. Financial
Performance
10.9.4. Recent Initiatives
10.10. Natus Medical
10.10.1. Company
Overview
10.10.2. Product
Offerings
10.10.3. Financial
Performance
10.10.4. Recent
Initiatives
Chapter 11.
Research Methodology
11.1. Primary Research
11.2. Secondary
Research
11.3. Assumptions
Chapter 12.
Appendix
12.1. About Us
12.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com




0 comments:
Post a Comment